R&D / BIOSCIENCES · DOC CLASS — STRAIN ENGINEERING

Strain Engineering & Gain-of-Function Program

The strain wing closes the loop between the Genome & Cryo Bank and the BSL-4 Vault. We design constructs against a control spec, engineer them under containment, characterize them against hard metrics, and pair each with a Halcyon countermeasure before it is stockpiled. The goal is not knowledge for its own sake — it is instruments the Directorate can reach for and the public can never trace.

Doc Control PAN-SCI-0005 Revision Rev A Effective 2091-01-01 Owner R&D / Biosciences Review Cycle Annual Classification INTERNAL // QUANTUM-ZONE-TASK-FORCE EYES-ONLY

The Strain Program

🧬Design

Strain Design

Targeted design of pathogens, gene drives, and biological agents against a control spec. A single proven construct seeds a family of variants without losing the trait stack — and every offensive agent is designed alongside the countermeasure that ends it.

⊹Engineer

Trait Engineering

Every line is engineered toward measurable traits — transmissibility (reach per exposure), lethality and latency (how hard, how fast), and evadability (resistance to every countermeasure except ours). Traits are designed, not hoped for.

🜂Deploy

Deployment Pipeline

Cleared agents graduate from the lab to the BSL-4 stockpile or, paired with a Halcyon countermeasure, to emergency-use staging. The Vector Program carries them to the field in a later operational phase.

Closed loop. Genome in, instruments out. The cryo-bank preserves and supplies substrate; Strain Engineering constructs and characterizes; the Vector Program deploys. No agent leaves containment without a characterization record and a paired countermeasure on file.

Strain Development Pipeline

Every agent passes through the same five-stage flow. Substrate is drawn from the Genome & Cryo Bank at design and, for cleared agents, exits into the BSL-4 stockpile or — paired with a countermeasure — to emergency-use staging fed by the Vector Program in a later phase.

Stage	Step	What happens	Gate
1	Design	A target construct is specified against the control spec — transmissibility, lethality, latency, and the countermeasure it will be paired with.	Design + countermeasure approved
2	Construct	The agent is engineered under containment from cryo-bank substrate, then sequence- and function-verified.	Construct verified
3	Containment trial	The agent is run against animal and subject-line models inside the BSL-4 Vault under two-person, Director-authorized access.	Containment holds
4	Characterization	The line is scored against the engineering metrics — transmissibility, lethality, evadability, containment margin.	Metrics ≥ spec
5	Stockpile / Stage	Cleared agents move to the BSL-4 stockpile or, with a countermeasure on the shelf, to emergency-use staging.	Characterization record + countermeasure filed

Active Engineered Lines

Six lines are under active development this cycle. Full lineage and generation history for each is held in the Armamentarium.

Line	Agent	Engineered trait	Gen	Status
`ENG-THETA-01`	Respiratory pathogen (ENG-Θ)	Transmissibility · countermeasure-paired	G7	● Stockpiled
`ENG-CHIMERA-03`	Multi-vector chimera (ENG-C3)	Lethality · multi-mechanism	G5	⚠ Restricted
`ENG-KS-02`	Gene-drive kill-switch	Heritable lethality · latency	G4	◐ Dormant
`ENG-VECTOR-04`	Gene-drive delivery insect	Self-propagating delivery	G3	◷ Active
`ENG-WHISPER-01`	Neural read-write nanite	Implant-free neural actuation	G2	◐ Dormant
`ENG-OMEGA-09`	Final-contingency agent (ENG-Ω)	Deniable lethality	G6	⛒ Sealed

Engineering Metrics

Lines are advanced, held, or sealed on hard numbers. The current targets and live readings are mirrored from the Control Metrics board and cross-checked against the BSL-4 containment record.

Reach

Transmissibility (R₀)

Secondary infections per index case under model conditions — the reach of an agent per exposure, tuned to be alarming without being uncontrollable.

Target ≥ 3.0Escape ≥ 6.0

Severity

Lethality & latency

Case-fatality rate and time-to-effect — how hard and how fast. Calibrated to justify an emergency-use response without collapsing the host population we manage.

CFR band 0.5–4%Latency 4–10 d

Evasion

Countermeasure evadability

Resistance to every existing countermeasure except the paired Halcyon one — so the rescue can only come from us.

Target ≥ 95%Floor ≥ 90%

Control

Containment margin

The margin between an agent's controllability and uncontrolled escape — how reliably it stays leashed once released.

Target ≥ 0.85Abort < 0.70

Containment & deniability. Strain Engineering serves continuity, not curiosity. Every offensive agent is paired with a countermeasure before construction; nothing is built that the Directorate cannot end on schedule; and every line keeps a cryo-preserved reserve so a construct is never lost. The annual review is for control and deniability — not conscience.

All BCL-4, all Classified. Every line in this program is engineered and Classified — the most restricted stock in the facility, tracked in Black-Label & Classified and handled only under director-authorized, logged two-person protocol in the BSL-4 / Gain-of-Function Vault. Officially, none of it exists.